Elsevier

Biomaterials

Volume 227, January 2020, 119573
Biomaterials

Single cell derived spheres of umbilical cord mesenchymal stem cells enhance cell stemness properties, survival ability and therapeutic potential on liver failure

https://doi.org/10.1016/j.biomaterials.2019.119573Get rights and content

Abstract

Umbilical cord mesenchymal stem cells (UCMSCs) have shown great potentials in regenerative medicine for their extensive sources, multilineage differentiation potential, low immunogenicity and self-renewal ability. However, the clinical application of UCMSCs still confronts many challenges including the requirement of large quantity of cells, low survival ability in vivo and the loss of main original characteristics due to two-dimensional (2D) culture. The traditional three-dimensional (3D)-spheroid culture can mimic in vivo conditions, but still has limitations in clinical application due to large size of spheroid against direct injection and inner cell death. Based on self-renewal tenet, we produced single cell derived sphere (SCDS) of UCMSCs through combining single cell pattern on chip with 3D culture. Compared with the 2D and traditional 3D culture, SCDS culture has many advantages to meet clinical requirements, including small size, higher abilities of survival and migration, and stronger hypoxia resistance and stemness maintenance. Furthermore, SCDS culture promotes angiogenesis in UCMSCs-xenografts and displays greater therapeutic potential on acute liver failure (ALF) in vivo. Our results suggest that SCDS culture may serve as a simple and effective strategy for UCMSCs optimization to meet clinical demand.

Introduction

Umbilical cord-derived mesenchymal stem cells (UCMSCs) are isolated from Wharton's jelly of umbilical cord and characterized by the abilities of self-renewal, multilineage differentiation, extensive proliferation and paracrine. They have exhibited multiple advantages such as easy isolation and harvest, lack of ethical concerns and tumorigenicity, and low immunogenicity [1,2]. As a result, UCMSCs hold significant promise for tissue engineering and regenerative medicine applications [3]. To date, UCMSCs have been widely used in multiple therapeutic studies such as acute lung injury, insulin-resistant diabetes, Alzheimer's disease (AD), acute myocardial infarction, graft-versus-host diseases (GVHD), aplastic anemia, arthrophlogosis, liver disease, spinal cord injury, systemic lupus erythematosus and stroke [[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14]].

In spite of many advantages, mesenchymal stem cells (MSCs) are still confronting challenges in clinical applications, such as requirement of large quantity of cells for therapy, heterogeneity of cell quality, low survival ability after transplantation, the attenuation of MSC characteristics in two-dimensional (2D) culture and ambiguous mechanism of MSCs function for disease therapy. The top priority for MSC therapy is to produce sufficient number of high-quality MSCs in vitro to meet clinical demand.

Generally, MSCs isolated from human tissues are cultured in 2D dishes as monolayer for fast expansion. However, 2D culture condition in vitro is far different from the native growth niche in vivo. It was reported that long-term 2D culture evoked a series of changes in MSCs including cellular senescence, immunogenicity, and losses of their stemness properties and paracrine activity [15,16]. Furthermore, 2D culture affected the genetic expression of cells and remodeled the internal structure of cells [[15], [16], [17], [18]].

Three-dimensional (3D) culture artificially creates an environment in which cells are permitted to grow or interact with their surroundings in all three dimensions. Therefore, 3D culture was widely regarded as a more preferable and closer physiological microenvironment for cells growth [[19], [20], [21]]. So far, many 3D culture methods have been developed to form MSC spheroids, such as hanging drop, magnetically levitate, chitosan membrane culture, microgravity bioreactor and rotating culture [[22], [23], [24], [25], [26]]. The common fundamental of these spheroid-formation methods was to provide cells with a suspension culture condition where the 3D spheroids were formed mainly relying on cell-cell adhesion and interaction that led to self-assembly tendency of MSCs [27,28]. That is, this type of spheroid is initially formed and derived from the aggregation of many individual cells. Here, we name this type of spheroid as multiple cells derived spheroid (MCDS). Growing evidences demonstrated that, by comparing with 2D culture, 3D MCDS culture enhanced the characteristics of MSCs on cell survival, factor secretion, stemness maintenance, migration, anti-senescence in vitro and enhanced the capacities of anti-inflammatory, angiogenesis, tissue repair and regeneration in vivo [[29], [30], [31], [32], [33], [34], [35]].

However, in spite of many advantages reported, obvious defects restrict the direct application of MCDS-cultured MSCs in clinic. First, the MCDS is initially composed of many individual MSCs that have difference viability, which causes the heterogeneity of cell quality in whole spheroid. Second, large size of MCDS results in different distributions of nutrients, oxygen, and waste metabolism between the core and periphery of spheroid. Third, the cells in core of MCDS are subjected to hostile metabolic stresses and tend to undergo apoptosis [28]. For example, lack of extracellular matrix (ECM) support may cause anoikis in the core of MCDS [36]. Forth, large size (diameter > 100 μm) lets MCDS unable to be directly injected into the body for the risk of blood vessel blockage. Therefore, MCDSs generally have to be dissociated into single cells by enzyme before vein-injection [25,37]. However, this dissociation process causes more cell damage and impairs cell viability [38].

The formation of single cell derived sphere (SCDS) reflects the potential of a cell to behave as a stem cell in vitro. Therefore, it has been widely used to evaluate self-renewal and differentiation at the single cell level and then to identify stem cells capacity [39]. Here, we speculate that the formation of SCDS can enhance MSCs stemness and then optimize the quality of MSCs to meet the demand of clinical application. To investigate this hypothesis, we developed a novel approach to produce UCMSC SCDS by combining 2D-pattern of single cell on chip with 3D culture. This technique enables single cells to be patterned on cell-array chip preventing from multicellular aggregation and cultured to form 3D spheres. Our in vitro results demonstrated that, compared to 2D- and MCDS-cultured UCMSCs, SCDS-cultured UCMSCs showed greater properties in many aspects such as stemness maintenance, anti-apoptosis, anti-senescence, hypoxia resistance and cell migration. In vivo results showed that SCDS culture improved cell survival and angiogenesis in UCMSC derived xenografts, and improved therapeutic potential of UCMSCs for carbon tetrachloride (CCl4)-induced acute liver failure (ALF). Our research indicates that SCDS culture may serve as a simple and effective strategy for MSCs optimization to meet clinical application.

Section snippets

Isolation, culture and identification of primary UCMSCs

Human umbilical cords were obtained from full-term infants delivered by caesarean section at Nanjing Drum Tower Hospital. The volunteers obtained written informed consent. The cords were delivered in a sterilized jar filled cold phosphate buffered saline (PBS) to the laboratory. The isolation and primary culture of UCMSCs was according to the method previously reported [40]. To isolate the UCMSCs, the mesenchymal tissue from the Wharton's jelly was minced into small pieces (0.5–1 cm3), evenly

Isolation and identification of UCMSCs

After 20 days of culture, primary cells grew out from the attached tissue blocks cells and began to assemble into groups. Most cells were spindle-shaped with prominent nucleoli. Tissue blocks were removed and cells were cultured to 80% confluence. These cells were named as P0 (passage 0) cells that were ready for passaging. Flow cytometry analysis showed that the isolated UCMSCs expressed high level of MSC markers such as CD44, CD73, CD90 and CD105, but negatively expressed CD11b, CD19, CD34,

Discussion

MSCs can be used as a powerful source in stem cell-based regenerative medicine for their abilities of differentiation, homing and paracrine [30,[63], [64], [65]]. The most realistic problem met in clinic is how to produce sufficient number of high-quality MSCs in vitro. Clinically, the conventional dose of UCMSCs is about 0.5 × 106–1 × 106/kg body/time, and total 4–8 times of administration is needed for one patient in whole process of therapy. Two-D culture is widely used to obtain a large

Conclusions

In this study, we developed a novel method to produce SCDS of UCMSCs based on 2D pattern of single cell on chip and 3D culture. For the first time, we reported that SCDS culture could markedly optimize UCMSCs for potentially meeting the demand of clinical application. Moreover, cell array chip is an appropriate tool for large-scale preparation of SCDSs and different size of MCDSs. In the future, SCDS-cultured UCMSCs may be hopefully used as high-quality cell source for regenerative medicine,

Acknowledgements

We thank Zhijun Zhang, Renjun Pei, Guosheng Cheng, and Qiangbin Wang for insightful comments on the study, Xiang He for her excellent technical assistance. This research was supported by funds from the Ministry of Science and Technology (MOST) (Grant 2017YFA0104301), National Natural Science Foundation of China (Grant 31870975), Suzhou Science and Technology Development Program (Grant SYG201835), Development Program of Ministry of Science and Technology (2016YFC1000802 and 2016YFC1000801), and

References (87)

  • R.R. Rayavarapu et al.

    The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment

    J. Biol. Chem.

    (2015)
  • M. Seiberg et al.

    The effects of trypsin on apoptosis, utriculi size, and skin elasticity in the Rhino mouse

    J. Investig. Dermatol.

    (1997)
  • E. Pastrana et al.

    Eyes wide open: a critical review of sphere-formation as an assay for stem cells

    Cell stem cell

    (2011)
  • J. Yan et al.

    The effect of surface charge on the cytotoxicity and uptake of carbon quantum dots in human umbilical cord derived mesenchymal stem cells

    Colloids Surfaces B Biointerfaces

    (2018)
  • R.K. Schneider et al.

    The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds

    Biomaterials

    (2010)
  • W. Tancharoen et al.

    Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells

    Acta Histochem.

    (2017)
  • M.C. Yang et al.

    The influence of rat mesenchymal stem cell CD44 surface markers on cell growth, fibronectin expression, and cardiomyogenic differentiation on silk fibroin - hyaluronic acid cardiac patches

    Biomaterials

    (2010)
  • K.J. Chou et al.

    CD44 fucosylation on mesenchymal stem cell enhances homing and macrophage polarization in ischemic kidney injury

    Exp. Cell Res.

    (2017)
  • Y. Zhou et al.

    The CXCL12 (SDF-1)/CXCR4 chemokine axis: oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy

    Chinese journal of natural medicines

    (2018)
  • C. Popa et al.

    The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

    J. Lipid Res.

    (2007)
  • C.S. Ong et al.

    In vivo therapeutic applications of cell spheroids

    Biotechnol. Adv.

    (2018)
  • I. Ben-Sahra et al.

    mTORC1 signaling and the metabolic control of cell growth

    Curr. Opin. Cell Biol.

    (2017)
  • T. Nacarelli et al.

    Targeting metabolism in cellular senescence, a role for intervention

    Mol. Cell. Endocrinol.

    (2017)
  • M.V. Gustafsson et al.

    Hypoxia requires notch signaling to maintain the undifferentiated cell state

    Dev. Cell

    (2005)
  • S.M. Devine et al.

    Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

    Blood

    (2003)
  • M.Y. Emmert et al.

    Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies

    Biomaterials

    (2013)
  • A. Bongso et al.

    The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord

    Stem Cell Rev.

    (2013)
  • D.C. Ding et al.

    Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy

    Cell Transplant.

    (2015)
  • R. El Omar et al.

    Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?, Tissue engineering

    Part B, Rev.

    (2014)
  • H. Zhu et al.

    Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice

    Sci. Rep.

    (2017)
  • Z. Xie et al.

    Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats

    Stem Cells

    (2016)
  • M. Lim et al.

    Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction

    Stem Cell Res. Ther.

    (2018)
  • L. Gao et al.

    Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation

    J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol.

    (2016)
  • L. Wang et al.

    Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy

    Stem Cells Dev.

    (2013)
  • L. Sun et al.

    Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

    Arthritis Rheum.

    (2010)
  • W. Liao et al.

    Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke

    Transplantation

    (2009)
  • S. Morikawa et al.

    Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow

    J. Exp. Med.

    (2009)
  • C. Toma et al.

    Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics

    Circ. Res.

    (2009)
  • D. Antoni et al.

    Three-dimensional cell culture: a breakthrough in vivo

    Int. J. Mol. Sci.

    (2015)
  • R. Edmondson et al.

    Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors

    Assay Drug Dev. Technol.

    (2014)
  • J. Lee et al.

    Three-dimensional cell culture matrices: state of the art

    Tissue Eng. B Rev.

    (2008)
  • N.S. Lewis et al.

    Magnetically levitated mesenchymal stem cell spheroids cultured with a collagen gel maintain phenotype and quiescence

    J. Tissue Eng.

    (2017)
  • F.A. Saleh et al.

    Three-dimensional in vitro culture techniques for mesenchymal stem cells

    Methods Mol. Biol.

    (2012)
  • Cited by (40)

    • Extracellular magnetic labeling of biomimetic hydrogel-induced human mesenchymal stem cell spheroids with ferumoxytol for MRI tracking

      2023, Bioactive Materials
      Citation Excerpt :

      MSC spheroids have been used in the repair of a variety of tissues and organs [33,34]. Numerous studies have shown that, compared with conventional cell culture methods using culture dishes, culturing of 3D MSC spheroids in vitro can significantly improve the directional differentiation, homing, anti-inflammatory, and paracrine capacities of MSCs [35–38]. However, the application of spheroids faces the following challenges: differences in spheroids prepared by various 3D culture methods and a lack of effective methods for tracking spheroids after transplantation.

    • High-efficient engineering of osteo-callus organoids for rapid bone regeneration within one month

      2022, Biomaterials
      Citation Excerpt :

      Taken together, the above analysis suggested the advantages of hydrogel MSs culture system in maintaining stem cell self-renewal and differentiation at transcriptional level. Although the micro-scale cell aggregates can fill up the irregular shape of the defect site, the endogenous bone regeneration may be hindered by the lack of enough vascularization and their terminal cell apoptosis, as well as the low-scaling production regarding large-sized bone defects [18]. The assembly of callus-like organoids by 3D printing into more complex structures and the subsequent chondrogenic differentiation at a certain stage were thus preferred for full bone regeneration.

    View all citing articles on Scopus
    1

    These authors are equal contribution to this work.

    View full text